SciTransfer
Organization

INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO

Serbian molecular genetics institute contributing to rare disease research, plastic biodegradation biotechnology, and sustained public science engagement across Europe.

Research institutehealthRS
H2020 projects
5
As coordinator
2
Total EC funding
€664K
Unique partners
165
What they do

Their core work

IMGGE is Serbia's leading molecular genetics and genetic engineering research institute, based in Belgrade. Their core work spans molecular biology, rare disease research, and applied biotechnology — particularly enzyme-based approaches to plastic degradation and circular economy solutions. They also run a long-standing public science engagement programme (SCIMFONICOM) that brings laboratory science to the general public through interactive events, open labs, and science demonstrations. In EU-funded research, they contribute specialist genetics and bioprocessing expertise to large international consortia.

Core expertise

What they specialise in

3 projects

Coordinated three editions of SCIMFONICOM (2014-15, 2018-19, 2020), a recurring public science outreach programme with open labs, science vans, and interactive demonstrations.

Biocatalysis and plastic biodegradationemerging
1 project

Participated in BioICEP (2020-2024), their largest funded project (EUR 473,500), focused on microbial consortia and enzymatic depolymerisation of plastics for circular economy.

Rare disease genomics and omicssecondary
1 project

Contributed to the European Joint Programme on Rare Diseases (EJP RD, 2019-2024) as a third party, working on omics data, FAIR data principles, and translational research.

Molecular genetics and genetic engineeringprimary
5 projects

Core institutional expertise underpinning all projects — from microbial genetics in BioICEP to genomic data in EJP RD and the scientific content of their public engagement events.

Evolution & trajectory

How they've shifted over time

Early focus
Public science engagement
Recent focus
Biotechnology and rare diseases

In the early H2020 period (2014-2019), IMGGE focused almost entirely on science communication, running the SCIMFONICOM public engagement events with themes like open labs, science vans, and green science. From 2019 onward, a clear shift occurred toward research-intensive participation: rare disease genomics through EJP RD and industrial biotechnology through BioICEP. This evolution suggests the institute used initial EU funding to build international visibility, then transitioned into substantive research consortia where their molecular biology expertise could be directly applied.

IMGGE is moving from outreach-only EU participation toward research-heavy roles in biotechnology and health, with their largest funding (BioICEP) signalling a serious push into circular bioeconomy.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European36 countries collaborated

IMGGE plays dual roles: they coordinate smaller science communication projects independently, while joining large international research consortia (165 partners across 36 countries) as a specialist contributor. Their coordinator experience is limited to the recurring SCIMFONICOM outreach events, while their research contributions come through participation or third-party arrangements in much larger programmes. This makes them a reliable but still-developing research partner — experienced in EU project management at a small scale, and increasingly embedded in major European research networks.

Despite only 5 projects, IMGGE has touched 165 unique consortium partners across 36 countries, primarily through the large EJP RD and BioICEP programmes. This gives them an unusually wide European network for a Serbian research institute of their size.

Why partner with them

What sets them apart

IMGGE is one of very few Serbian research institutes with a continuous H2020 track record spanning 2014-2024, combining both public engagement and deep research roles. Their dual profile — science communication expertise plus molecular genetics research — makes them a distinctive partner for projects that need both technical contributions and dissemination capacity. For consortium builders targeting Western Balkans participation or Widening Country requirements, IMGGE offers proven EU project experience and a broad existing network.

Notable projects

Highlights from their portfolio

  • BioICEP
    Their largest project by far (EUR 473,500), focused on enzymatic plastic degradation — represents IMGGE's strategic move into applied industrial biotechnology and circular economy research.
  • EJP RD
    A massive European Joint Programme on Rare Diseases connecting IMGGE to a pan-European health research network, broadening their profile well beyond their traditional genetics focus.
  • SCIMFONICOM 2014-15
    The first of three recurring public engagement projects that IMGGE coordinated, establishing them as a consistent science communication organiser in Serbia.
Cross-sector capabilities
Environment and circular bioeconomyScience communication and public engagementBiotechnology and bioprocessingFAIR data and open science
Analysis note: With only 5 projects — 3 of which are editions of the same outreach event — the research profile is built primarily on two substantive projects (BioICEP and EJP RD). The molecular genetics and biotechnology expertise is inferred from institutional identity and project roles rather than a deep portfolio of research outputs. Confidence would increase significantly with more research-focused project participation.